Your institution may have access to this item. Find your institution then sign in to continue.
Title
Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitis.
Authors
Sullivan, Patrick W; Follin, Sheryl L; Nichol, Michael B
Abstract
The majority of individuals with allergic rhinitis in the US take first-generation antihistamines (FGAs). Although FGAs have been proven effective in alleviating allergic rhinitis symptoms, they have been associated with an increased risk of motor vehicle, aviation and occupational injuries and deaths, reduced productivity and impaired learning.